Open Access

Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy

  • Authors:
    • Lei Zhang
    • Shen Qu
    • Aibin Liang
    • Hong Jiang
    • Hao Wang
  • View Affiliations

  • Published online on: November 26, 2014     https://doi.org/10.3892/ijmm.2014.2011
  • Pages: 333-339
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to explore novel target genes that regulate the development of diabetic neuropathy (DN) by analyzing gene expression profiles in the sciatic nerve of infected mice. The GSE11343 microarray dataset, which was downloaded from Gene Expression Omnibus, included data on 4 control samples and 5 samples from mice with diabetes induced by streptozotocin (STZ), 5 samples from normal mice treated with rosiglitazone (Rosi) and 5 samples from mice with diabetes induced by STZ and treated with Rosi. Differentially expressed genes (DEGs) between the different groups were identified using the substitution augmentation modification redefinition (SAMR) model. The Gene Ontology (GO) term and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID). Regulatory and protein‑protein interaction networks were searched using BioCarta and STRING, respectively. The protein structures of potential regulatory genes were predicted using the SYBYL program. Compared with the controls, 1,384 DEGs were identified in the mice with STZ-induced diabetes and 7 DEGs were identified in the mice treated with Rosi. There were 518 DEGs identified between the mice in the STZ + Rosi and STZ groups. We identified 45 GO items, and the calmodulin nerve phosphatase and chemokine signaling pathways were identified as the main pathways. Three genes [myristoylated alanine-rich protein kinase C substrate (Marcks), GLI pathogenesis-related 2 (Glipr2) and centrosomal protein 170 kDa (Cep170)] were found to be co-regulated by both STZ and Rosi, the protein structure of which was predicted and certain binding activity to Rosi was docked. Our study demonstrates that the Marcks, Glipr2 and Cep170 genes may be underlying drug targets in the treatment of DN.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 35 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang L, Qu S, Liang A, Jiang H and Wang H: Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy. Int J Mol Med 35: 333-339, 2015.
APA
Zhang, L., Qu, S., Liang, A., Jiang, H., & Wang, H. (2015). Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy. International Journal of Molecular Medicine, 35, 333-339. https://doi.org/10.3892/ijmm.2014.2011
MLA
Zhang, L., Qu, S., Liang, A., Jiang, H., Wang, H."Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy". International Journal of Molecular Medicine 35.2 (2015): 333-339.
Chicago
Zhang, L., Qu, S., Liang, A., Jiang, H., Wang, H."Gene expression microarray analysis of the sciatic nerve of mice with diabetic neuropathy". International Journal of Molecular Medicine 35, no. 2 (2015): 333-339. https://doi.org/10.3892/ijmm.2014.2011